ABEONA THERAPEUTICS INC. (ABEO) Free cash flow 2016–2025
ABEONA THERAPEUTICS INC. (ABEO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$84.3MFY2025 · since FY2016: -$13.5M → -$84.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$84.3M | -44.2% |
| FY2024 | -$58.5M | -56.6% |
| FY2023 | -$37.3M | +14.4% |
| FY2022 | -$43.6M | +37.5% |
| FY2021 | -$69.8M | -92.0% |
| FY2020 | -$36.4M | +47.4% |
| FY2019 | -$69.1M | -43.0% |
| FY2018 | -$48.4M | -105.6% |
| FY2017 | -$23.5M | -73.8% |
| FY2016 | -$13.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ABEO financial trends
ABEO RevenueABEO Net incomeABEO Net marginABEO Gross profitABEO Gross marginABEO Operating incomeABEO Operating marginABEO Operating cash flowABEO Capital expendituresABEO Return on equityABEO Stock buybacksABEO Dividends paidABEO Total assetsABEO Total liabilitiesABEO Shareholders’ equityABEO overview →